Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2007

01.08.2007 | Original Paper

Significance of Enhanced Expression of Nitric Oxide Syntheses in Splenic Sinus Lining Cells in Altered Portal Hemodynamics of Idiopathic Portal Hypertension

verfasst von: Yasunori Sato, Seiko Sawada, Kazuto Kozaka, Kenichi Harada, Motoko Sasaki, Osamu Matsui, Yasuni Nakanuma

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Idiopathic portal hypertension (IPH) is characterized by noncirrhotic portal hypertension due mainly to increased intrahepatic, presinusoidal resistance to portal blood flow. Marked splenomegaly is always seen in IPH. To clarify the pathogenetic significance of splenomegaly, immunohistochemical expression of inducible nitric oxide synthese (iNOS), endothelial NOS (eNOS), and endothelin-1 (ET-1) in spleens from patients with IPH was examined. Sinus lining cells of IPH spleens showed diffuse and strong expression of iNOS and eNOS. Sinus lining cells of spleens from patients with liver cirrhosis (LC) also showed positive signals for iNOS and eNOS, but the staining intensity was significantly weak. ET-1 was detectable in only a few mononuclear leukocytes in the red pulp of both IPH and LC spleens. These results suggest that NO liberated in spleen, rather than ET-1, is responsible for the dilatation of splenic sinuses, leading to splenomegaly, and thereby contributes to portal hypertension in IPH.
Literatur
1.
Zurück zum Zitat Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K (2001) Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 197:65–76PubMedCrossRef Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K (2001) Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 197:65–76PubMedCrossRef
2.
Zurück zum Zitat Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, Kurumaya H, Harada A, Obata H (1996) Histopathology of the liver in noncirrhotic portal hypertension of unknown aetiology. Histopathology 28:195–204PubMedCrossRef Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, Kurumaya H, Harada A, Obata H (1996) Histopathology of the liver in noncirrhotic portal hypertension of unknown aetiology. Histopathology 28:195–204PubMedCrossRef
3.
Zurück zum Zitat Okudaira M, Ohbu M, Okuda K (2002) Idiopathic portal hypertension and its pathology. Semin Liver Dis 22:59–72PubMedCrossRef Okudaira M, Ohbu M, Okuda K (2002) Idiopathic portal hypertension and its pathology. Semin Liver Dis 22:59–72PubMedCrossRef
4.
Zurück zum Zitat Okuda K, Kono K, Ohnishi K, et al. (1984) Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86:600–610PubMed Okuda K, Kono K, Ohnishi K, et al. (1984) Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86:600–610PubMed
5.
Zurück zum Zitat Tsuneyama K, Ohba K, Zen Y, Sato Y, Niwa H, Minato H, Nakanuma Y (2003) A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 43:55–61PubMedCrossRef Tsuneyama K, Ohba K, Zen Y, Sato Y, Niwa H, Minato H, Nakanuma Y (2003) A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 43:55–61PubMedCrossRef
6.
Zurück zum Zitat Tsuneyama K, Kouda W, Nakanuma Y (2002) Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study. Pathol Res Pract 198:597–603PubMedCrossRef Tsuneyama K, Kouda W, Nakanuma Y (2002) Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study. Pathol Res Pract 198:597–603PubMedCrossRef
7.
Zurück zum Zitat Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, Puri P, Mitra SK, Suri S (2002) Noncirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 17:6–16PubMedCrossRef Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, Puri P, Mitra SK, Suri S (2002) Noncirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 17:6–16PubMedCrossRef
8.
Zurück zum Zitat Maesawa C, Sakuma T, Sato T, Masuda T, Muro-oka G, Satodate R (1995) Structural characteristic of splenic sinuses in idiopathic portal hypertension. Pathol Int 45:642–648PubMed Maesawa C, Sakuma T, Sato T, Masuda T, Muro-oka G, Satodate R (1995) Structural characteristic of splenic sinuses in idiopathic portal hypertension. Pathol Int 45:642–648PubMed
9.
Zurück zum Zitat Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M, Sugimachi K (2002) Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol 17:59–65PubMedCrossRef Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M, Sugimachi K (2002) Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol 17:59–65PubMedCrossRef
10.
Zurück zum Zitat Kaido T, Oe H, Yoshikawa A, Okajima A, Imamura M (2004) Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepatogastroenterology 51:547–551PubMed Kaido T, Oe H, Yoshikawa A, Okajima A, Imamura M (2004) Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepatogastroenterology 51:547–551PubMed
11.
Zurück zum Zitat Rockey D (1997) The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 25:2–5PubMedCrossRef Rockey D (1997) The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 25:2–5PubMedCrossRef
12.
Zurück zum Zitat Wiest R, Groszmann RJ (1999) Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 19:411–426PubMedCrossRef Wiest R, Groszmann RJ (1999) Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 19:411–426PubMedCrossRef
14.
Zurück zum Zitat Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863–2867PubMedCrossRef Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863–2867PubMedCrossRef
15.
Zurück zum Zitat Nagasue N, Dhar DK, Yamanoi A, Emi Y, Udagawa J, Yamamoto A, Tachibana M, Kubota H, Kohno H, Harada T (2000) Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis. Hepatology 31:1107–1114PubMedCrossRef Nagasue N, Dhar DK, Yamanoi A, Emi Y, Udagawa J, Yamamoto A, Tachibana M, Kubota H, Kohno H, Harada T (2000) Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis. Hepatology 31:1107–1114PubMedCrossRef
16.
Zurück zum Zitat Ohara N, Futagawa S, Watanabe S, Fukasawa M, Takamori S (2001) Clinical investigation of endothelin-1 and nitric oxide in patients with portal hypertension focusing on plasma levels and immunohistological staining of liver tissues. Hepatol Res 21:40–54CrossRefPubMed Ohara N, Futagawa S, Watanabe S, Fukasawa M, Takamori S (2001) Clinical investigation of endothelin-1 and nitric oxide in patients with portal hypertension focusing on plasma levels and immunohistological staining of liver tissues. Hepatol Res 21:40–54CrossRefPubMed
17.
Zurück zum Zitat Yamamoto K (1978) Morphological studies of the spleen in splenomegalic liver cirrhosis comparing with the spleen in idiopathic portal hypertension (so-called Banti’s syndrome without liver cirrhosis). Acta Pathol Jpn 28:891–905PubMed Yamamoto K (1978) Morphological studies of the spleen in splenomegalic liver cirrhosis comparing with the spleen in idiopathic portal hypertension (so-called Banti’s syndrome without liver cirrhosis). Acta Pathol Jpn 28:891–905PubMed
18.
Zurück zum Zitat Cavalli G, Re G, Casali AM, Monari P (1982) The microvascular architecture of spleen in congestive splenomegaly. A morphological-histometric study. Pathol Res Pract 174:131–146 Cavalli G, Re G, Casali AM, Monari P (1982) The microvascular architecture of spleen in congestive splenomegaly. A morphological-histometric study. Pathol Res Pract 174:131–146
19.
Zurück zum Zitat Suzuki T (1972) Application of scanning electron microscopy in the study of the human spleen: three dimensional fine structure of the normal red pulp and its changes as seen in splenomegalias associated with Banti’s syndrome and cirrhosis of the liver. Nippon Ketsueki Gakkai Zasshi 35:506–522PubMed Suzuki T (1972) Application of scanning electron microscopy in the study of the human spleen: three dimensional fine structure of the normal red pulp and its changes as seen in splenomegalias associated with Banti’s syndrome and cirrhosis of the liver. Nippon Ketsueki Gakkai Zasshi 35:506–522PubMed
20.
21.
Zurück zum Zitat Kamath PS, Carpenter HA, Lloyd RV, McKusick MA, Steers JL, Nagorney DM, Miller VM (2000) Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver. Liver Transpl 6:596–602PubMedCrossRef Kamath PS, Carpenter HA, Lloyd RV, McKusick MA, Steers JL, Nagorney DM, Miller VM (2000) Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver. Liver Transpl 6:596–602PubMedCrossRef
22.
Zurück zum Zitat Blendis L, Wong F (2001) The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 89:221–231PubMedCrossRef Blendis L, Wong F (2001) The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 89:221–231PubMedCrossRef
Metadaten
Titel
Significance of Enhanced Expression of Nitric Oxide Syntheses in Splenic Sinus Lining Cells in Altered Portal Hemodynamics of Idiopathic Portal Hypertension
verfasst von
Yasunori Sato
Seiko Sawada
Kazuto Kozaka
Kenichi Harada
Motoko Sasaki
Osamu Matsui
Yasuni Nakanuma
Publikationsdatum
01.08.2007
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2007
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9146-9

Weitere Artikel der Ausgabe 8/2007

Digestive Diseases and Sciences 8/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.